Australian Ethical (ASX:AEF) Reports Record Growth in Funds Under Management
Australian Ethical (ASX:AEF) reports record FUM of $13.26 billion, driven by strong investment performance and positive net flows.
Australian Ethical (ASX:AEF) reports record FUM of $13.26 billion, driven by strong investment performance and positive net flows.
PolyNovo Limited (ASX:PNV) reports a strong 22.8% revenue increase in 1H FY25, with significant growth in the US and worldwide sales.
Emmerson Resources Limited announces expanded drilling at White Devil Gold Project with upcoming resource estimates and assay results.
Ardea Resources updates on the DFS for its Kalgoorlie Nickel Project, showcasing drilling progress and team recruitment efforts.
Immuron Limited (ASX: IMC) reports a 249% increase in Travelan® sales, indicating significant growth in both domestic and international markets.
Reach Resources (ASX: RR1) reveals strong gold and REE potential in December 2024 quarterly activities report.
Neurizon Therapeutics Limited announces FDA has placed its NUZ-001 IND application under clinical hold, seeking further information.
Archer Materials (ASX:AXE) reports progress in quantum projects and TMR sensor technology with a strong cash position in Q2 FY25.
Singular Health (ASX: SHG) confirms successful Phase 1 completion with PNS, advancing to Phase 2 in its medical imaging project.
Lynas Rare Earths Ltd (ASX:LYC) announces significant revenue growth and operational advancements for Q2 FY25 despite market challenges.